Open Access
Subscription or Fee Access
The Unseen World Within: Decoding the Intricacies of Gut Microbiota and Its Impact on Human Health
Abstract
This comprehensive review delves into the multifaceted role of the gut microbiota in human health, elucidating its impact on diverse physiological processes, immune responses, and metabolic diseases. The intricate interplay of diet, genetics, and environmental factors is explored in shaping the composition and function of the gut microbiota, with consequential effects on conditions ranging from metabolic disorders to inflammatory bowel diseases and mental health. Therapeutic interventions, including probiotics, prebiotics, and fecal microbiota transplantation, are examined for their potential in modulating gut microbiota and improving health outcomes. The integration of microbiome profiling into personalized medicine is highlighted as a promising avenue for advancing diagnostics and treatments across various health conditions. As ongoing research continues to unravel the complexities of the gut microbiota, this review underscores its profound impact on human health, emphasizing the emerging potential for innovative preventive and therapeutic strategies. Furthermore, this review delves into the intricate mechanisms through which the gut microbiota influences human health, shedding light on its role in modulating immune responses, regulating energy metabolism, and even impacting neurobehavioral functions. By meticulously examining the intricate interplay of dietary patterns, host genetics, and environmental factors, the review provides deeper insights into the factors shaping the diversity and stability of the gut microbiota, thus influencing susceptibility to various diseases. Moreover, it critically evaluates the therapeutic potential of interventions such as dietary modifications, microbial supplementation, and microbiota-targeted medications in restoring microbial balance and ameliorating disease states. Additionally, the review underscores the significance of ongoing research efforts aimed at elucidating the complex interactions within the gut microbiome and their implications for personalized healthcare approaches. In conclusion, this comprehensive review underscores the pivotal role of the gut microbiota in human health and disease, while highlighting the exciting prospects for innovative preventive and therapeutic strategies in the evolving landscape of microbiome-based medicine.
References
Sokol, Harry. "Definition and roles of the gut microbiota." La Revue du Praticien 69.7 (2019): 776-782.
Dogra, Shaillay Kumar, Joel Doré, and Sami Damak. "Gut microbiota resilience: definition, link to health and strategies for intervention." Frontiers in microbiology 11 (2020): 572921.
Li, Cheng, and Yiming Hu. "New definition of resistant starch types from the gut microbiota perspectives–a review." Critical Reviews in Food Science and Nutrition 63.23 (2023): 6412-6422.
Williams, Brianna B., et al. "Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine." Cell host & microbe 16.4 (2014): 495-503.
Sawano, Tatsuya, Takeshi Imamura, and Junichiro Miake. "Gut microbiota and cardiovascular disease--insights into the potential and challenges of drug discovery--." Folia Pharmacologica Japonica 158.5 (2023).
Xia, Fan, et al. "Gut microbiota as a target for prevention and treatment of type 2 diabetes: Mechanisms and dietary natural products." World Journal of Diabetes 12.8 (2021): 1146.
Ruigrok, Renate AAA, Rinse K. Weersma, and Arnau Vich Vila. "The emerging role of the small intestinal microbiota in human health and disease." Gut Microbes 15.1 (2023): 2201155.
Safina, D. D., N. B. Amirov, and S. R. Abdulkhakov. "Gut microbiota and its importance for human health." (2021).
Olvera-Rosales, Laura-Berenice, et al. "Impact of the gut microbiota balance on the health–disease relationship: The importance of consuming probiotics and prebiotics." Foods 10.6 (2021): 1261.
Chen-Liaw, Alice Y. Gut microbiota bacterial strain richness is species specific and limits therapeutic engraftment. Diss. Icahn School of Medicine at Mount Sinai, 2023.
Khiabani, Siamak Amini, et al. "Diversity of Bacteroidaceae family in gut microbiota of patients with chronic kidney disease and end stage renal disease." Health Promotion Perspectives 13.3 (2023): 237.
Chung, Youn Wook, et al. "Functional dynamics of bacterial species in the mouse gut microbiome revealed by metagenomic and metatranscriptomic analyses." PLoS One 15.1 (2020): e0227886.
Wang, Hao, et al. "Gut virome of mammals and birds reveals high genetic diversity of the family Microviridae." Virus Evolution 5.1 (2019): vez013.
Hoffmann, Christian, et al. "Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents." PloS one 8.6 (2013): e66019.
Alonso, Virginia Robles, and Francisco Guarner. "Intestinal microbiota composition in adults." Probiotic Bacteria and Their Effect on Human Health and Well-Being. Vol. 107. Karger Publishers, 2013. 17-24.
Novak, K. Šik, et al. "Diet And Gut Microbiota Composition." Clinical Nutrition ESPEN 54 (2023): 619.
Ozsoy, Serpil, Nazife Sultanoglu, and Tamer Sanlidag. "The role of Mediterranean diet and gut microbiota in type-2 diabetes mellitus associated with obesity (diabesity)." Journal of Preventive Medicine and Hygiene 63.2 Suppl 3 (2022): E87.
Huda, M. Nazmul, et al. "Gut microbiota and host genetics modulate the effect of diverse diet patterns on metabolic health." Frontiers in Nutrition 9 (2022): 896348.
Rinninella, Emanuele, et al. "What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases." Microorganisms 7.1 (2019): 14.
Rothschild, Daphna, et al. "Environment dominates over host genetics in shaping human gut microbiota." Nature 555.7695 (2018): 210-215.
Hernandez, Juan, et al. "Domestic environment and gut microbiota: lessons from pet dogs." Microorganisms 10.5 (2022): 949.
Portincasa, Piero, et al. "Gut microbiota and short chain fatty acids: implications in glucose homeostasis." International journal of molecular sciences 23.3 (2022): 1105.
Xiao, Ruiming, et al. "The in vitro fermentation of compound oral liquid by human colonic microbiota altered the abundance of probiotics and short-chain fatty acid production." RSC advances 12.46 (2022): 30076-30084.
Ohira, Hideo, Wao Tsutsui, and Yoshio Fujioka. "Are short chain fatty acids in gut microbiota defensive players for inflammation and atherosclerosis?" Journal of atherosclerosis and thrombosis 24.7 (2017): 660-672.
Topol, Inna A., Irina S. Polyakova, and Anna V. Elykova. "Role of intestinal microbiota in regulation of immune reactions of gut-associated lymphoid tissue under stress and following the modulation of its composition by antibiotics and probiotics administration." Journal of microbiology, epidemiology and immunobiology 99.6 (2022): 722-733.
Topol, Inna A., Irina S. Polyakova, and Anna V. Elykova. "Role of intestinal microbiota in regulation of immune reactions of gut-associated lymphoid tissue under stress and following the modulation of its composition by antibiotics and probiotics administration." Journal of microbiology, epidemiology and immunobiology 99.6 (2022): 722-733.
Kasarello, Kaja, and Elzbieta M. Sajdel-Sulkowska. "Developmental significance of early gut-associated lymphoid tissue (GALT)-microbiota interactions in health and disease: creating balance between tolerance and inflammation in children." Open Journal of Pediatrics and Child Health 4.1 (2019): 040-046.
Morais, Livia H., Henry L. Schreiber IV, and Sarkis K. Mazmanian. "The gut microbiota–brain axis in behaviour and brain disorders." Nature Reviews Microbiology 19.4 (2021): 241-255.
Ahmed, Hany, et al. "Microbiota-derived metabolites as drivers of gut–brain communication." Gut Microbes 14.1 (2022): 2102878.
Ceppa, Florencia, Andrea Mancini, and Kieran Tuohy. "Current evidence linking diet to gut microbiota and brain development and function." International journal of food sciences and nutrition 70.1 (2019): 1-19.
Hulme, Heather, et al. "Mapping the influence of the gut microbiota on small molecules across the microbiome gut brain axis." Journal of the American Society for Mass Spectrometry 33.4 (2022): 649-659.
Cooke, Matthew B et al. “Examining the Influence of the Human Gut Microbiota on Cognition and Stress: A Systematic Review of the Literature.” Nutrients vol. 14,21 4623. 2 Nov. 2022, doi:10.3390/nu14214623
Ceppa, Florencia et al. “Current evidence linking diet to gut microbiota and brain development and function.” International journal of food sciences and nutrition vol. 70,1 (2019): 1-19. doi:10.1080/09637486.2018.1462309
Moszak, Małgorzata et al. “Does gut microbiota affect the success of weight loss? Evidence and speculation.” Nutrition (Burbank, Los Angeles County, Calif.) vol. 116 (2023): 112111. doi: 10.1016/j.nut.2023.112111
Johnstone, Alexandra M et al. “Nondigestible Carbohydrates Affect Metabolic Health and Gut Microbiota in Overweight Adults after Weight Loss.” The Journal of nutrition vol. 150,7 (2020): 1859-1870. doi:10.1093/jn/nxaa124
Gou, Wanglong et al. “Gut microbiota, inflammation, and molecular signatures of host response to infection.” Journal of genetics and genomics = Yi chuan xue bao vol. 48,9 (2021): 792-802. doi: 10.1016/j.jgg.2021.04.002
Wen, Li, and Andrew Duffy. “Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes.” The Journal of nutrition vol. 147,7 (2017): 1468S-1475S. doi:10.3945/jn.116.240754
Li, Nannan et al. “Fecal microbiota transplantation from chronic unpredictable mild stress mice donors affects anxiety-like and depression-like behavior in recipient mice via the gut microbiota-inflammation-brain axis.” Stress (Amsterdam, Netherlands) vol. 22,5 (2019): 592-602. doi:10.1080/10253890.2019.1617267
Al-Busaidi, Alsalt et al. “Gut Microbiota and Insulin Resistance: Understanding the Mechanism of Better Treatment of Type 2 Diabetes Mellitus.” Current diabetes reviews, 10.2174/0115733998281910231231051814. 17 Jan. 2024, doi:10.2174/0115733998281910231231051814
Guo, Qian. “Bioinformatics analysis of the diversity of gut microbiota and different microbiota on insulin resistance in diabetes mellitus patients.” Heliyon vol. 9,12 e22117. 10 Nov. 2023, doi:10.1016/j.heliyon.2023.e22117
Katamadze, Natia et al. “THE ROLE OF GUT MICROBIOTA IN PATIENTS WITH DIABETES TYPE 2 AND INSULIN RESISTANCE.” TSMU COLLECTION OF SCIENTIFIC WORKS (2021): n. pag.
Palmnäs-Bédard, Marie S A et al. “The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs.” The American journal of clinical nutrition vol. 116,4 (2022): 862-874. doi:10.1093/ajcn/nqac217
Al-Busaidi, Alsalt et al. “Gut Microbiota and Insulin Resistance: Understanding the Mechanism of Better Treatment of Type 2 Diabetes Mellitus.” Current diabetes reviews, 10.2174/0115733998281910231231051814. 17 Jan. 2024, doi:10.2174/0115733998281910231231051814
Wen, Li, and Andrew Duffy. “Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes.” The Journal of nutrition vol. 147,7 (2017): 1468S-1475S. doi:10.3945/jn.116.240754
Dahiya, Divakar, and Poonam Singh Nigam. “Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer.” International journal of molecular sciences vol. 24,6 5748. 17 Mar. 2023, doi:10.3390/ijms24065748
Alula, Kibrom M et al. “Interplay of gut microbiota and host epithelial mitochondrial dysfunction is necessary for the development of spontaneous intestinal inflammation in mice.” Microbiome vol. 11,1 256. 17 Nov. 2023, doi:10.1186/s40168-023-01686-9
Moreno, Carlos M et al. “Immunomodulatory role of oral microbiota in inflammatory diseases and allergic conditions.” Frontiers in allergy vol. 4 1067483. 17 Feb. 2023, doi:10.3389/falgy.2023.1067483
Abril, Ana G et al. “The Role of the Gallbladder, the Intestinal Barrier and the Gut Microbiota in the Development of Food Allergies and Other Disorders.” International journal of molecular sciences vol. 23,22 14333. 18 Nov. 2022, doi:10.3390/ijms232214333
Drapkina, Oxana M et al. “Targeting Gut Microbiota as a Novel Strategy for Prevention and Treatment of Hypertension, Atrial Fibrillation and Heart Failure: Current Knowledge and Future Perspectives.” Biomedicines vol. 10,8 2019. 19 Aug. 2022, doi:10.3390/biomedicines10082019
Ke, Alfred et al. “Current and Future Perspectives on the Role of Probiotics, Prebiotics, and Synbiotics in Controlling Pathogenic Cronobacter Spp. in Infants.” Frontiers in microbiology vol. 12 755083. 21 Oct. 2021, doi:10.3389/fmicb.2021.755083
Sharma, Varruchi et al. “Probiotics and Prebiotics Having Broad Spectrum Anticancer Therapeutic Potential: Recent Trends and Future Perspectives.” Current Pharmacology Reports 7 (2021): 67-79.
Sharma, Varruchi et al. “Probiotics and Prebiotics Having Broad Spectrum Anticancer Therapeutic Potential: Recent Trends and Future Perspectives.” Current Pharmacology Reports 7 (2021): 67 - 79.
Doll, Jessica P K et al. “Fecal Microbiota Transplantation (FMT) as an Adjunctive Therapy for Depression-Case Report.” Frontiers in psychiatry vol. 13 815422. 17 Feb. 2022, doi:10.3389/fpsyt.2022.815422
Zhang, Wanying et al. “Fecal Microbiota Transplantation (FMT) Alleviates Experimental Colitis in Mice by Gut Microbiota Regulation.” Journal of microbiology and biotechnology vol. 30,8 (2020): 1132-1141. doi:10.4014/jmb.2002.02044
Leonardi, Irina et al. “Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis.” Cell host & microbe vol. 27,5 (2020): 823-829.e3. doi: 10.1016/j.chom.2020.03.006
Ramai, Daryl et al. “Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.” Digestive diseases and sciences vol. 66,2 (2021): 369-380. doi:10.1007/s10620-020-06185-7
Chuong, Kim H et al. “Human Microbiome and Learning Healthcare Systems: Integrating Research and Precision Medicine for Inflammatory Bowel Disease.” Omics: a journal of integrative biology vol. 22,2 (2018): 119-126. doi:10.1089/omi.2016.0185
Dudley, Joel T et al. “Personalized medicine: from genotypes, molecular phenotypes and the quantified self, towards improved medicine.” Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing (2015): 342-6.
Segal, Eran. “Harnessing Big Data for Personalized Medicine.” Proceedings of the 14th ACM International Conference on Web Search and Data Mining (2021): n. pag.
Everett, Jeremy R.. “NMR-based Pharmacometabonomics: A New Approach to Personalized Medicine.” (2015).
Xiu, Ruipu et al. “Mapping Research Trends and Hotspots in the Link between Alzheimer's Disease and Gut Microbes over the Past Decade: A Bibliometric Analysis.” Nutrients vol. 15,14 3203. 19 Jul. 2023, doi:10.3390/nu15143203
Doll, Jessica P K et al. “Fecal Microbiota Transplantation (FMT) as an Adjunctive Therapy for Depression-Case Report.” Frontiers in psychiatry vol. 13 815422. 17 Feb. 2022, doi:10.3389/fpsyt.2022.815422
Leonardi, Irina et al. “Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis.” Cell host & microbe vol. 27,5 (2020): 823-829.e3. doi:10.1016/j.chom.2020.03.006
DOI: https://doi.org/10.37591/rrjomv.v13i3.3417
Refbacks
- There are currently no refbacks.